Analytical Data
-
Gene name
STX2
- Application
-
Alternative Names
EPIM; EPM; STX2A; STX2B; STX2C; Epimorphin
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P32856
-
Expression Region
Leu8~Arg262
-
Molecular Weight
34kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STX2, or Syntaxin 2, is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein family, which plays a critical role in the vesicular transport processes that are essential for intracellular communication, particularly in neurons and immune cells. Research into STX2 recombinant protein has gained significant attention due to its involvement in exocytosis, the mechanism by which cells release substances, including neurotransmitters and hormones. Dysregulation of STX2 has been linked to various physiological and pathological conditions, such as neurodegenerative diseases and immune responses. Understanding the structure and function of STX2 not only enhances our knowledge of vesicle trafficking but also opens up potential therapeutic avenues for conditions where this process is disrupted. The production of STX2 as a recombinant protein allows for detailed biochemical and biophysical studies, facilitating the exploration of its interactions with other SNARE proteins and regulatory factors. Additionally, by producing STX2 in a controlled system, researchers can investigate its role in specific cellular contexts, paving the way for targeted interventions in diseases where STX2 functionality is compromised. Overall, the study of STX2 recombinant protein is crucial for elucidating the complexities of cellular communication and developing novel strategies for disease treatment.
